abiraterone,olaparib
astrazeneca,janssen,merck
['biomarker', 'propel', 'olaparib', 'prostate', 'crpc', 'marker ']
excellent propel updates from dr. fred saad showing ongoing rpfs benefit from 1l mcrpc treatment w/ olaparib + abi. look forward to ongoing os updates and biomarker data #esmo22 #prostatecancer 
Medical Oncologist, Chair Southern Alberta GU Tumour Group, Tom Baker Cancer Centre. Opinions are my own.